<DOC>
	<DOCNO>NCT00728416</DOCNO>
	<brief_summary>This study seek prospectively demonstrate Nasonex good placebo relieve nasal congestion patient seasonal allergic rhinitis .</brief_summary>
	<brief_title>Study Nasonex Relief Nasal Congestion Patients With Seasonal Allergic Rhinitis ( Study P05583 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>A subject must 12 year age old , either sex , race . A subject must least 2year history SAR exacerbate study season . A subject must positive skin prick test response appropriate seasonal allergen Visit 1 . A subject must clinically symptomatic Screening Baseline Visits . A subject history severe local reaction ( ) anaphylaxis skin testing . A subject upper respiratory tract sinus infection require antibiotic therapy without least 14day washout prior Screening Visit , viral upper respiratory infection within 7 day prior Screening Visit . A subject use drug investigational protocol 30 day prior Screening Visit . A subject participate clinical study . A subject part staff personnel directly involve study . A subject family member ( parent , spouse , sibling ) investigational study staff . A female subject breastfeeding , pregnant , intend become pregnant . A subject previously randomize study . A subject family member ( parent , spouse , sibling ) currently enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>